Lv, Duo-Duo <br/><br/>
A retrospective study of the efficacy of sofosbuvir plus NS5A inhibitors for patients with hepatitis C virus genotype-2 chronic infection.  [electronic resource] 

 -  European journal of gastroenterology & hepatology  03 2019 
 - 382-388 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1473-5687 
<br/><br/><label>Standard No.: </label>10.1097/MEG.0000000000001299  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--adverse effects<br/>Benzimidazoles--adverse effects<br/>Carbamates--adverse effects<br/>Drug Combinations<br/>Drug Therapy, Combination<br/>Female<br/>Fluorenes--adverse effects<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--complications<br/>Heterocyclic Compounds, 4 or More Rings--adverse effects<br/>Humans<br/>Imidazoles--adverse effects<br/>Liver Cirrhosis--diagnosis<br/>Male<br/>Middle Aged<br/>Pyrrolidines<br/>RNA, Viral--blood<br/>Retrospective Studies<br/>Sofosbuvir--adverse effects<br/>Sustained Virologic Response<br/>Time Factors<br/>Treatment Outcome<br/>Uridine Monophosphate--adverse effects<br/>Valine--analogs & derivatives<br/>Viral Load<br/>Viral Nonstructural Proteins--antagonists & inhibitors